Adicet Bio, Inc. (ACET) financial statements and ratios from SEC XBRL: revenue $5.78M (TTM), net margin -2021.9%, revenue growth -46.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $5.78M |
| Net Margin | -2021.9% |
| Revenue Growth (YoY) | -46.1% |
| EPS Growth (YoY) | 1174.4% |
| FCF Growth (YoY) | 3.7% |
| Price / Book | 0.71 |
| Price / Sales | 17.09 |
| FCF Yield | -187.1% |
| Altman Z-Score | -4.11 (distress) |
| Sector P/E (Healthcare) | 21.7 |
ACET overview · ACET earnings · ACET KPIs · ACET investor relations · ACET ownership · ACET peers · ACET filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.